Could Food Be a New Medicine to Fight Heart Disease?

Cleveland HeartLab diet, heart attack and stroke, metabolic syndrome

A compound called DMB (3,3-dimethyl-1-butanol), found in olive oil, red wine and other foods, may someday be a first-of-its kind drug with the potential to treat—or even prevent—heart disease in the future, suggests a new Cleveland Clinic study published in the journal Cell. The investigators report that in mice, dietary supplementation with this naturally occurring compound safely inhibited atherosclerosis (plaque more »

TMAO Testing: A New Way To Assess Heart Attack And Stroke Risk

Cleveland HeartLab biomarkers, heart attack and stroke, TMAO

A new blood test that measures levels of TMAO (trimethylamine-N-oxide) — a metabolite derived from gut bacteria — can powerfully predict future risk for heart attack, stroke, and death in patients who appear otherwise healthy, according to pioneering Cleveland Clinic research. The new test — now available through Cleveland HeartLab — measures blood levels of TMAO, a compound produced by more »

Dangerous Cluster of Heart Disease & Diabetes Risks Affects 35% of Americans

Cleveland HeartLab diabetes, inflammation, metabolic syndrome

More than one in three US adults have metabolic syndrome, a combination of at least three of five pre-disease-state factors, that doubles risk for heart disease and quintuples the risk for type 2 diabetes, according to a new study published in the Journal of the American Medical Association.  The study reported that from 2003-2004 to 2011-2012, overall rates of metabolic syndrome more »